Luteolin inhibits hyperglycemia-induced epithelial-mesenchymal transition and malignant progression in gastric cancer via targeting AKR1B1-mediated glucose metabolism.
Saved in:
| Title: | Luteolin inhibits hyperglycemia-induced epithelial-mesenchymal transition and malignant progression in gastric cancer via targeting AKR1B1-mediated glucose metabolism. |
|---|---|
| Authors: | He Q; Department of Traditional Chinese Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No.365 Renmin East Road, Jinhua, 321000, Zhejiang, China., Tao F; Department of Traditional Chinese Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No.365 Renmin East Road, Jinhua, 321000, Zhejiang, China., Wen X; Department of Traditional Chinese Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No.365 Renmin East Road, Jinhua, 321000, Zhejiang, China., Zhu L; Department of Traditional Chinese Medicine Pharmacy, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, Zhejiang, China., Ye X; Department of Traditional Chinese Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No.365 Renmin East Road, Jinhua, 321000, Zhejiang, China. YeXuxing6857@163.com. |
| Source: | Clinical & experimental metastasis [Clin Exp Metastasis] 2026 Jul 14; Vol. 43 (4). Date of Electronic Publication: 2026 Jul 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7276 (Electronic) Linking ISSN: 02620898 NLM ISO Abbreviation: Clin Exp Metastasis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
